Inpharmica

inpharmica

Project Description

Problem: The company has been involved in a project aimed at performing phase III of clinical studies on an increased number of patients, including the monitoring of undesired effects and development of documentation to register a new complex pain killer patented in the USA.

Partners: The project has been carried on in a consortium established in close cooperation with the Medical University of Warsaw.

Innovation: a unique global-scale solution carried out on the basis of a patent.

Mentor:

Founded:

Activities: